Peptide Injections AI
Home/About/Alex Evans, PharmD, MBA
AE

Alex Evans, PharmD, MBA

PharmDMBA

Clinical Reviewer & Co-Founder

Doctor of Pharmacy (PharmD) with MBA. Clinical reviewer ensuring medical accuracy across all content.

About Alex

Dr. Alex Evans is the clinical reviewer and co-founder of Peptide Injections AI. As a Doctor of Pharmacy (PharmD) with an MBA, Alex brings both clinical expertise and business acumen to the platform.

He reviews all peptide therapy content, provider evaluations, and medication guides for clinical accuracy, drug interactions, and regulatory compliance. Alex is the co-founder and Head of Content at Experts.Ink, a medical writing agency employing licensed clinicians across disciplines — including PharmDs, MDs, DOs, RNs, RDs, and other licensed healthcare professionals. His clinical background ensures that every recommendation on the platform meets the highest standards of medical accuracy and patient safety.

Areas of Expertise

  • Clinical Pharmacy
  • Peptide Pharmacology
  • Drug Interactions & Safety
  • Regulatory Compliance
  • Compounding Pharmacy Standards
  • Evidence-Based Medicine

Affiliations

Experts.Ink

Co-Founder & Head of Content

Peptide Injections AI

Co-Founder & Clinical Reviewer

Network Credentials

PharmDMBACFACPAPTDPTBSNRNPHNRDLDBCPSCPEAAHIVPDVM+13 more

Professional Organizations

Our editorial network holds memberships in leading medical writing and science communication organizations:

American Medical Writers Association (AMWA)
International Society for Medical Publication Professionals (ISMPP)
National Association of Science Writers (NASW)
Council of Science Editors
Author's Guild
Editorial Freelancers Association (EFA)

Our Editorial Standards

Every page on Peptide Injections AI is reviewed by our editorial team for accuracy, completeness, and compliance with medical information standards.

Clinician-Reviewed

All content reviewed by licensed PharmD

Evidence-Based

Sourced from FDA, PubMed, ClinicalTrials.gov

Updated Regularly

Provider data verified weekly via automated systems